Pending the results of ongoing clinical trials with rapamycin, these studies suggest that combination therapy with rapamycin and drugs that block receptor activation of ...New insight into autoimmune disease: Bacterial infections promote recognition of self-glycolipids...ibute to some autoimmune diseases such as multiple sclerosis (MS) and Guillain-Barre syndrome (GBS).